Search results

Interested in a scholarship or graduate position at ANSTO? Review the opportunities at a glance.

Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.

Peter Kabokov will continue work that will contribute to defence industry

A Powerhouse exhibition was recognised with a prestigious Museums and Galleries National Award for Research at a ceremony in Perth this morning.  The Invisible Revealed exhibition was organised in collaboration with ANSTO and the University of NSW.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

Radiocarbon measurements at ANSTO’s Centre for Accelerator Science have supported research published that provided insights into what the environment was like for the Aboriginal artists who created rock art over intervals spanning 43,000 years.

Neutron Activation Analysis (NAA) is a highly sensitive method of quantitative elemental analysis. There is a wide range of potential applications for neutron irradiations.

An investigation that set out to resolve some of the uncertainty in the sources and quantities of pollutants reaching Antarctica has produced a new experimental technique to identify and characterise recently terrestrially-influenced air reaching Antarctica.

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

Nuclear science is applied by ANSTO's scientists in many areas that are vital to Australia's future, including agriculture, industry and manufacturing, minerals construction, health and environment. Our work in the development and applications and new knowledge and skills arises from world-class experience in nuclear science and technologies.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

Technology at heart of award-winning wastewater innovation from BioGill.